Neonatal screening for severe combined immunodeficiency in Brazil;Triagem neonatal para imunodeficiência combinada grave no Brasil

Jornal de Pediatria

Volumn 92, Issue 4, 2016, Pages 374-380

  Kanegae, Marilia Pyles Patto ^a   Barreiros, Lucila Akune ^a   Mazzucchelli, Juliana Themudo Lessa ^b   Hadachi, Sonia Marchezi ^c   de Figueiredo Ferreira Guilhoto, Laura Maria ^c   Acquesta, Ana Lúcia ^d   Genov, Isabel Rugue ^b,e   Holanda, Silvia Maia ^f   Di Gesu, Regina Sumiko Watanabe ^g   Goulart, Ana Lucia ^b   dos Santos, Amélia Miyashiro Nunes ^b   Bellesi, Newton ^h   Costa Carvalho, Beatriz Tavares ^b   Condino Neto, Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Associacao de Pais e Amigos dos Excepcionais de Sao Paulo   (Brazil)

^d Hospital Geral de Pirajussara   (Brazil)

^e Hospital Pimentas Bonsucesso   (Brazil)

^f Amparo Maternal   (Brazil)

^g HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^h Clin de Med Preventiva de Para   (Brazil)

Author keywords

Combined immunodeficiency; Neonatal screening; Primary immunodeficiency; SCID; T lymphocytes; TRECs

Indexed keywords

DNA; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; BLOOD SAMPLING; BRAZIL; CONTROLLED STUDY; DIGEORGE SYNDROME; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE; NEWBORN; NEWBORN SCREENING; PREMATURITY; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SEVERE COMBINED IMMUNODEFICIENCY; T CELL RECEPTOR EXCISION CIRCLES QUANTIFICATION TECHNIQUE; AGE; BLOOD; DRIED BLOOD SPOT TESTING; FEMALE; GENETICS; MALE; NONPARAMETRIC TEST; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TIME FACTOR;

AGE FACTORS; BRAZIL; DRIED BLOOD SPOT TESTING; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERE COMBINED IMMUNODEFICIENCY; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84973573515     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jped.2015.10.006     Document Type: Article

References (24)

1. 1 Buckley, R.H., Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22 (2004), 625–655.
2. 2 Dvorak, C.C., Cowan, M.J., Logan, B.R., Notarangelo, L.D., Griffith, L.M., Puck, J.M., et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol 33 (2013), 1156–1164.
3. 3 Baker, M.W., Grossman, W.J., Laessig, R.H., Hoffman, G.L., Brokopp, C.D., Kurtycz, D.F., et al. Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol 124 (2009), 522–527.
4. 4 Chan, K., Puck, J.M., Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115 (2005), 391–398.
5. 5 Borte, S., von Dobeln, U., Fasth, A., Wang, N., Janzi, M., Winiarski, J., et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 119 (2012), 2552–2555.
6. 6 Kwan, A., Abraham, R.S., Currier, R., Brower, A., Andruszewski, K., Abbott, J.K., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 (2014), 729–738.
7. 7 Baker, M.W., Laessig, R.H., Katcher, M.L., Routes, J.M., Grossman, W.J., Verbsky, J., et al. Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program. Public Health Rep 125:Suppl. 2 (2010), 88–95.
8. 8 Carneiro-Sampaio, M., Moraes-Vasconcelos, D., Kokron, C.M., Jacob, C.M., Toledo-Barros, M., Dorna, M.B., et al. Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol 33 (2013), 716–724.
9. 9 Dantas, E.O., Aranda, C.S., Rego Silva, A.M., Tavares, F.S., Severo Ferreira, J.F., de Quadros Coelho, M.A., et al. Doctors’ awareness concerning primary immunodeficiencies in Brazil. Allergol Immunopathol (Madr) 43 (2015), 272–278.
10. 10 Mazzucchelli, J.T., Bonfim, C., Castro, G.G., Condino-Neto, A.A., Costa, N.M., Cunha, L., et al. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol 24 (2014), 184–191.
11. 11 Douek, D.C., Vescio, R.A., Betts, M.R., Brenchley, J.M., Hill, B.J., Zhang, L., et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355 (2000), 1875–1881.
12. 12 Routes, J., Abinun, M., Al-Herz, W., Bustamante, J., Condino-Neto, A., De La Morena, M.T., et al. ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol 34 (2014), 398–424.
13. 13 De Villartay, J.P., Schwarz, K., Villa, A., V(D)J recombination defects. Ochs, H.D., Edvard Smith, C.I., Puck, J.M., (eds.) Primary immunodeficiency diseases: a molecular and genetic approach, 2nd ed., 2007, Oxford University Press, New York, 153–168.
14. 14 van der Spek, J., Groenwold, R.H., van der Burg, M., van Montfrans, J.M., TREC based newborn screening for severe combined immunodeficiency disease: a systematic review. J Clin Immunol 35 (2015), 416–430.
15. 15 Ward, C.E., Baptist, A.P., Challenges of newborn severe combined immunodeficiency screening among premature infants. Pediatrics 131 (2013), e1298–e1302.
16. 16 Silveira, E.L., Hiperplasia adrenal congênita no Brasil: incidência, custos da triagem neonatal e aplicação clínica da biologia molecular. [Thesis], 2005, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS.
17. 17 IBGE, Estatísticas de Registro Civil. 2013 Available from: http://www.ibge.gov.br/home/estatistica/populacao/registrocivil/2013/default_xls.shtm [cited 18.09.15].
18. 18 Brasil. Ministério da Saúde. Portaria N° 2.829, de 14 de dezembro de 2012.
19. 19 Gaspar, H.B., Hammarstrom, L., Mahlaoui, N., Borte, M., Borte, S., The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J Clin Immunol 34 (2014), 393–397.
20. 20 Puck, J.M., Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 120 (2007), 760–768.
21. 21 Kubiak, C., Jyonouchi, S., Kuo, C., Garcia-Lloret, M., Dorsey, M.J., Sleasman, J., et al. Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency. J Allergy Clin Immunol Pract 2 (2014), 697–702.
22. 22 Chan, K., Davis, J., Pai, S.Y., Bonilla, F.A., Puck, J.M., Apkon, M., A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab 104 (2011), 383–389.
23. 23 Olbrich, P., de Felipe, B., Delgado-Pecellin, C., Rodero, R., Rojas, P., Aguayo, J., et al. A first pilot study on the neonatal screening of primary immunodeficiencies in Spain: TRECS and KRECS identify severe T- and B-cell lymphopenia]. An Pediatr (Barc) 81 (2014), 310–317.
24. 24 Moraes-Pinto, M.I., Ono, E., Santos-Valente, E.C., Almeida, L.C., Andrade, P.R., Dinelli, M.I.S., et al. Lymphocyte subsets in human immunodeficiency virus-unexposed Brazilian individuals from birth to adulthood. Mem Inst Oswaldo Cruz 109 (2014), 989–998.